Trials / Terminated
TerminatedNCT03920059
Fixed-dose Versus Concentration-controlled Mycophenolate Mofetil for the Treatment of Active Lupus Nephritis
A Randomized Open-label Study of Fixed-dose Versus Concentration-controlled Mycophenolate Mofetil for the Treatment of Active Lupus Nephritis
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- Chulalongkorn University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
A randomized open-label study of fixed-dose versus concentration-controlled mycophenolate mofetil for treatment of active lupus nephritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mycophenolate Mofetil | Description Each capsule contains Mycophenolate mofetil 250 mg. Presentation / Packing Cap 250 mg (white to off white powder, light blue/peach hard gelatin, imprinting with "MMF" on cap and "250" on body) x 10 x 10's. Storage Store below 30 degree Celcius. |
Timeline
- Start date
- 2019-08-20
- Primary completion
- 2020-01-30
- Completion
- 2020-01-30
- First posted
- 2019-04-18
- Last updated
- 2021-02-01
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT03920059. Inclusion in this directory is not an endorsement.